#Sputnik V

Sputnik V, Russia's COVID vaccine is said to have 91% efficacy and will be used in India for emergency use. (Photo Credit: Unsplash)

  • Sputnik V, Russia's COVID-19 vaccine was approved by Indian government for emergency use, earlier this month
  • The vaccine will initially be imported, until the production starts in the next quarter
  • Companies that will produce the vaccine, include Hetero Biopharma, Gland Pharma, Stelis Biopharma and Panacea Biotec 

India has vaccinated 10.45 crore people according to data published by the Union health ministry on Monday. (Photo credit: Representative image/Unsplash)

After Covishield and Covaxin, Sputnik V will become the third Covid-19 vaccine to be used in India

.Brussels, Belgium
The Sputnik V is tempting many countries in the EU. (Photo Credits: PTI Photo)

  • Hungary on Tuesday received its first batch of 40,000 Sputnik V doses
  • While none of the bloc's other 26 nations have gone as far, some appear tempted
  • Brussels has been wary of the Russian and Chinese vaccines

.Moscow, Russia
Experts have since been convinced of the effectiveness of the Russian coronavirus vaccine, Sputnik V. (Photo Credit: Representational/unsplash)

  • Last year in mid-August, Vladimir Putin announced the approval of world's first coronavirus vaccine
  • Russia made the vaccine available to the wider public in December
  • The success of the vaccine restores Russian research capabilities to the world's top echelons,

.Moscow, Russia
The new analysis included about 20,000 volunteers. (Photo Credit: Representational/ Unsplash)

  • The Phase 3 trials suggest that the two-dose Sputnik V vaccination provides more than 90% efficacy
  • The authors of the study said that the efficacy was only calculated on symptomatic cases
  • Russia has already launched a mass inoculation campaign for its citizens

.Brasília - Brasilia, Federal District, Brazil
Brazil has recorded more than 8.45 million coronavirus cases and two million deaths. (Photo Credit: AFP)

  • Brazil on Sunday granted emergency use authorisation to two COVID-19 vaccines
  • It approved the use of vaccines developed by China’s Sinovac and Britain’s AstraZeneca
  • Uniao Quimica, a partner of Russian Direct Investment Fund, had applied for emergency use of Sputnik V

.Moscow, Russia
A shot of Russia's experimental Sputnik V coronavirus vaccine is shown before its use in Moscow. (Photo Credit: AP/PTI)

  • Twitter lifted restrictions briefly imposed on the account promoting the Sputnik V vaccine
  • The account was block for “some unusual activity,” Twitter said
  • The brief restriction of access was due to “a possible security breach from Virginia, USA”.

.Moscow, Russia
Vladimir Putin said Sputnik V is 'much simpler and more effective.' (Photo Credit: AP/PTI)

  • Russia will launch mass coronavirus vaccinations from next week
  • Russia registered Sputnik V in August, months ahead of Western competitors
  • The country has been battered by a second wave of coronavirus infections in recent months

.New Delhi, Delhi, India
India is set to launch its COVID-19 vaccination drive from January 16. (Photo Credit: PTI)

  • Zydus Cadilla  has been granted approval for Phase 3 clinical trials
  • Phase 1 clinical trials of Biological E vaccine started in December and Phase 2 is expected to begin in March
  • India had recently granted emergency use authorisation to Oxford's Covishield and Bharat Biotech's Covaxin

.Moscow, Russia
Critics of the Kremlin have called the vaccination drive a geopolitical push.( Photo Credit: AP / PTI)

  • The development of Sputnik V was financed by Russian Direct Investment Fund (RDIF)
  • No other details about the distribution of the vaccine has been given out except the figure
  • Consultations with WHO for the use of Sputnik in case of emergencies will start from January 20